1-10 of 10
Joyce B. Reome
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice

Maria de la Luz Garcia-Hernandez, Hiromasa Hamada, Joyce B. Reome, Sara K. Misra, Michael P. Tighe, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2010) 184 (8): 4215–4227.
https://doi.org/10.4049/jimmunol.0902995
Published: 15 April 2010
View articletitled, Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice
Open the PDF for Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice in another window
Add to Citation Manager for Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice
Journal Articles

The mechanism of protection against influenza by transfer of Tc17, an IL-17 secreting CD8 T cell subset. (46.5)

Hiromasa Hamada, Maria de la Luz Garcia-Hernandez, Joyce B. Reome, Sara K. Misra, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2009) 182 (1_Supplement): 46.5.
https://doi.org/10.4049/jimmunol.182.Supp.46.5
Published: 01 April 2009
View articletitled, The mechanism of protection against influenza by transfer of Tc17, an IL-17 secreting CD8 T cell subset. (46.5)
Add to Citation Manager for The mechanism of protection against influenza by transfer of Tc17, an IL-17 secreting CD8 T cell subset. (46.5)
Journal Articles

Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge

Hiromasa Hamada, Maria de la Luz Garcia-Hernandez, Joyce B. Reome, Sara K. Misra, Tara M. Strutt, Kai K. McKinstry, Andrea M. Cooper, Susan L. Swain, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2009) 182 (6): 3469–3481.
https://doi.org/10.4049/jimmunol.0801814
Published: 15 March 2009
View articletitled, Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
Open the PDF for Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge in another window
Add to Citation Manager for Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
Journal Articles

CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer

Mark J. Dobrzanski, Joyce B. Reome, James C. Hylind, Kathleen A. Rewers-Felkins
Journal: The Journal of Immunology
J Immunol (2006) 177 (11): 8191–8201.
https://doi.org/10.4049/jimmunol.177.11.8191
Published: 01 December 2006
View articletitled, CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer
Open the PDF for CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer in another window
Add to Citation Manager for CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer
Journal Articles

Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses

Mark J. Dobrzanski, Joyce B. Reome, Joseph A. Hollenbaugh, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2004) 172 (3): 1380–1390.
https://doi.org/10.4049/jimmunol.172.3.1380
Published: 01 February 2004
View articletitled, Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses
Open the PDF for Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses in another window
Add to Citation Manager for Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses
Journal Articles

Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection

Mark J. Dobrzanski, Joyce B. Reome, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2001) 167 (1): 424–434.
https://doi.org/10.4049/jimmunol.167.1.424
Published: 01 July 2001
View articletitled, Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
Open the PDF for Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection in another window
Add to Citation Manager for Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
Journal Articles

The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System

Joyce B. Reome, Darrin S. Johnston, Brian K. Helmich, Tammy M. Morgan, Nicholas Dutton-Swain, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2000) 165 (8): 4226–4230.
https://doi.org/10.4049/jimmunol.165.8.4226
Published: 15 October 2000
View articletitled, The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System
Open the PDF for The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System in another window
Add to Citation Manager for The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System
Journal Articles

Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor

Mark J. Dobrzanski, Joyce B. Reome, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (2000) 164 (2): 916–925.
https://doi.org/10.4049/jimmunol.164.2.916
Published: 15 January 2000
View articletitled, Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor
Open the PDF for Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor in another window
Add to Citation Manager for Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor
Journal Articles

Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases

Mark J. Dobrzanski, Joyce B. Reome, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (1999) 162 (11): 6671–6680.
https://doi.org/10.4049/jimmunol.162.11.6671
Published: 01 June 1999
View articletitled, Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases
Open the PDF for Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases in another window
Add to Citation Manager for Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases
Journal Articles

In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines

Adelheid Cerwenka, Laura L. Carter, Joyce B. Reome, Susan L. Swain, Richard W. Dutton
Journal: The Journal of Immunology
J Immunol (1998) 161 (1): 97–105.
https://doi.org/10.4049/jimmunol.161.1.97
Published: 01 July 1998
View articletitled, In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines
Open the PDF for In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines in another window
Add to Citation Manager for In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines